Prostate Cancer Clinical Trials Update With Dr. Keith Crawford (PHEN)

December 2019 Clinical Trials Update With Dr. Keith Crawford from the Prostate Health Education Network

Visit http://www.prostatehealthed.org/phen_tv_video.php?tv_id=291 for monthly updates on clinical trials

Most Recent

Predicting Psoriatic Arthritis in Psoriasis Patients

Researchers have identified several clinical characteristics of psoriasis patients that may increase the risk of developing psoriatic arthritis. A single-center, retrospective cohort study examined the clinical profiles of psoriasis patients to determine the precursors of psoriatic arthritis (PsA), aiming to bridge the gap between psoriasis management and the identification of psoriatic arthritis risk. The study’s...

Psoriatic Arthritis

Rheumatology

Guselkumab in Practice: A Real-World Assessment of Psoriatic Arthritis Treatment

Guselkumab, a targeted inhibitor of interleukin-23, has emerged as a promising therapy for psoriatic arthritis, offering hope for improved patient outcomes. A prospective multicenter study aimed to shed light on the effectiveness of using guselkumab for psoriatic arthritis (PsA) management by analyzing the experiences of PsA patients over 6 months. The study also looked at...

Psoriatic Arthritis

Rheumatology

Impact of Diagnostic Delays in Psoriatic Arthritis

Newly published data from a prospective cohort study indicate that diagnosing psoriatic arthritis within 12 weeks after symptom onset may represent a clinical window of opportunity for achieving minimal disease activity and disease remission. In rheumatoid arthritis, the benefits of early treatment within 12 weeks following symptom onset are well-documented, leading to better remission rates,...